Introduction
============

Multi-protein complexes (I--V) embedded within the mitochondrial inner membrane are responsible for the production of cellular energy generating ATP molecules through the process of oxidative phosphorylation (OXPHOS). Defects in this process are responsible for severe diseases in humans ([@B12]; [@B23]). The OXPHOS system has a double genetic origin: nuclear and mitochondrial. Pathogenic mutations that compromise cellular energy production can therefore be found in both the nuclear and mitochondrial genomes.

Complexes I--IV transfer electrons to oxygen coupled to a vectorial proton translocation across the mitochondrial inner membrane. The resulting transmembrane proton gradient is used by complex V, the ATP synthase, to synthesize ATP from ADP and inorganic phosphate ([@B8]; [@B33]; [@B2]; [@B41]). The ATP synthase consists of two distinct domains, a globular matrix-localized catalytic unit called F~1~, and a membrane-embedded proton-translocating domain known as F~0~. In mitochondria, F~1~ is an assembly of five different subunits with an α~3~β~3~γδε stoichiometry, that contains three catalytic sites located in the β-subunits ([@B1]; [@B7]; [@B22]). The synthesis of ATP by the β-subunits depends upon rotation of the F~1~ sub-complex (called the central stalk) formed by subunits γ, δ, and ε that connects F~1~ to the proton-translocating domain (F~0~) of ATP synthase ([@B22]). The main components involved in proton translocation are a ring of *c*-subunits (8 in human and 10 in yeast; [@B37]; [@B41]) and a single subunit *a* ([@B36]; [@B13]). Direct contacts between the *c*-ring and subunits γ and δ enable the *c*-ring and the central stalk to rotate together as a fixed ensemble during catalysis ([@B37]; [@B39]). The F~1~ is also physically connected to F~0~ via its external surface by a peripheral stalk, composed in yeast of single copies of the subunits OSCP, 4, d, h, f, 8, and i ([@B40]; [@B2]; [@B11]); this structure acts as a stator to counter the tendency of the α~3~β~3~ moiety to follow the rotation of the central stalk during catalysis. The mitochondrial ATP synthase exists as a dimer ([@B5]), a structure mediated by subunits e and g that is important for cristae formation ([@B3]; [@B27]). The ATPase activity of the yeast mitochondrial ATP synthase is also regulated by several peptides (If1, Stf1, and Stf2; [@B18]).

The biogenesis of ATP synthase is a particularly complex process, which involves a number of protein factors having specific actions in the expression of the mitochondrial DNA-encoded subunits and in the establishment of proper subunit interactions ([@B2]; [@B11]; [@B30]). The ATP synthase assembly pathway has been extensively studied in *Saccharomyces cerevisiae* ([@B2]; [@B24]; [@B30], [@B28]). Although the yeast and human ATP synthases are highly similar, there must be some differences in their assembly pathways, because factors involved in the biogenesis of the yeast enzyme are not conserved in humans and *vice versa* ([@B9]; [@B20]).

Diseases caused by ATP synthase defects have been associated to mitochondrial DNA mutations in the genes encoding subunits *a* and A6L ([@B24]). Autosomal recessive nuclear mutations have also been reported in genes (ATP12 and TMEM70) encoding ATP synthase assembly factors ([@B10]; [@B9]) and structural subunits (ε and α; [@B25]; [@B21]). All these mutations share a common biochemical phenotype with a decreased content of fully assembled ATP synthase.

The ε-subunit mutation was found in a 22 years old patient presenting with neonatal onset, lactic acidosis, 3-methylglutaconic aciduria, mild mental retardation, and peripheral neuropathy ([@B25]). This was a homozygous missense mutation replacing a highly conserved tyrosine in position 12 of the protein with cysteine. This mutation caused a substantial decrease in the rate of mitochondrial ATP synthesis apparently because of a reduced content in fully assembled ATP synthase. The authors concluded that ε-subunit has an essential role in the biosynthesis and assembly of the F~1~ domain of ATP synthase.

In the yeast *S. cerevisiae*, evidence was provided that the ε-subunit is not required for the assembly of the other subunits of ATP synthase ([@B38]). However, a lack in the ε-subunit rapidly results in F~0~-mediated proton leaks through the membrane, showing that the ε-subunit is in yeast essential for the coupling of the F~1~ and F~0~ domains of ATP synthase ([@B38]). In order to better understand how the Y12C mutation in ε-subunit affects ATP synthase, we have created a yeast model of this mutation. The results show that this mutation has only a limited impact on activity and assembly of ATP synthase in yeast.

Materials and Methods {#s1}
=====================

Strains and Media
-----------------

*Escherichia coli* NEB-5alpha strain (BioLabs) was used for the cloning and propagation of plasmids. The *S. cerevisiae* strains used and their genotypes are listed in **Table [1](#T1){ref-type="table"}**. The following rich media were used for the growth of yeast: 1% (w/v) yeast extract, 1% (w/v) peptone, 40 mg/l adenine, 2% (w/v) glucose, 2% (w/v) galactose, 2% (w/v) glycerol, or 2% (w/v) lactate. The glycerol medium was buffered at pH 6.2 with 50 mM potassium phosphate, and 2% (w/v) ethanol was added after sterilization. We also used complete synthetic medium (CSM) 0.17% (w/v) yeast nitrogen base without amino acids and ammonium sulfate, 0.5% (w/v) ammonium sulfate, 2% (w/v) glucose, and 0.8% (w/v) of a mixture of amino acids and bases from Formedium. The solid media contained 2% (w/v) agar.

###### 

Genotypes of yeast strains.

  Name     Nuclear genotype                                                                                    mtDNA           Source
  -------- --------------------------------------------------------------------------------------------------- --------------- ------------
  YE1      *Mat*α *ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 arg8::HIS3 atp15::KanMX* + pCM189*-ATP15*        ρ^+^*Arg8^m^*   [@B38]
  Y11C     *Mat*α *ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 arg8::HIS3 atp15::KanMX* + pES425*-ATP15-Y11C*   ρ^+^*Arg8^m^*   This study
  hATP5E   *Mat*α *ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 arg8::HIS3 atp15::KanMX* + pCM189*-hATP5E*       ρ^+^*Arg8^m^*   This study

Construction of a Yeast Strain Expressing the Yeast Subunit ε (WT and Mutant Y11C)
----------------------------------------------------------------------------------

Yeast strain (YE1) expressing WT ε-subunit was described previously ([@B38]). To obtain the yeast epsilon Y11C mutant, the codon TAT (31/33) was mutated to TgT to replace tyrosine 11 with cysteine. The coding sequence of the ε-subunit gene (*ATP15*) was amplified by PCR with Phusion DNA polymerase (Fermentas) using DNA from strain W303-1B as a template and the primers EY11C-5Hind (5^′^-aaaaagcttATGTCTGCCTGGAGGAAAGCTGGTATATCA[TgT]{.ul}GGCTGCATATTTG-3^′^) that include the mutation (underlined) for the sense strand and EY11C-3 (5^′^-aaagcggccgcCTATTTTGTTATTGGAGTGGGTTCAGAAGCTGCAGTGCC-3^′^) for the antisense strand. The PCR product was digested with *Hin*dIII--*Not*I and ligated into the vector pES425 (marker leucine, Doron Rapaport) to produce plasmid pES425-Y11C. The cloned gene was verified by DNA sequencing. The YE1 strain was transformed with pES425-Y11C and selected on synthetic complete medium lacking uracil and leucine. The resulting strain that contains two different plasmids (pCM189-ε WT and pES425-Y11C) was subsequently cultured for about 10 generations in a medium containing uracil allowing the lost of the pCM189-ε WT plasmid. One clone called Y11C in a ρ^+^ state and containing only pES425-Y11C plasmid was retained for further analysis.

Construction of a Yeast Strain Expressing the Human Subunit ε (hATP5E) Under the Control of a Doxycycline-Repressible Promoter
------------------------------------------------------------------------------------------------------------------------------

The coding sequence of the human ε-subunit gene (*ATP5E*) was amplified by PCR using cDNA obtained from human HeLa cells as a template and primers hATP5E-5BamXho (5^′^-ttt[ggatccctcgag]{.ul}**ATG**GTGGCCTACTGGAGACAGGCTGGACTCAGC-3^′^) and hATP5E-3ClaNot (5^′^-aaa[gcggccgcatcgat]{.ul}**TTA**TTCCTTCTTTACTTTCACAATTTTTACGTTG-3^′^) for the antisense strand. The PCR product was digested with *Bam*HI--*Not*I and ligated into the vector pCM189 ([@B14]) to produce plasmid pCM189-hATP5E. The cloned gene was verified by DNA sequencing. Y11C strain was transformed with pCM189-hATP5E and selected on synthetic complete medium lacking uracil and leucine. The resulting strain that contains two different plasmids (pES425-Y11C and pCM189-hATP5E) was subsequently cultured for about 5--7 generations in a medium containing leucine allowing the lost of the pES425-Y11C plasmid. One clone, hATP5E wild-type (WT) human ε, isolated from a ρ^+^ clone, and containing only pCM189-hATP5E plasmid was retained for further analysis.

Miscellaneous Procedures
------------------------

The oxygen consumption of cells was measured polarographically at 28°C using a Clark oxygen electrode in a 1 ml thermostatically controlled chamber. Respiratory rates were determined from the slope of a plot of O~2~ concentration versus time. Cell oxygen consumption was measured in fresh cultured media (CSM-galactose, OD~600~ = 2) and isolated mitochondria oxygen consumption was measured in the respiration buffer (0.65 M mannitol, 0.36 mM EGTA, 5 mM Tris-phosphate, 10 mM Tris-maleate, pH 6.8) as previously described ([@B31]). Isolated mitochondria were prepared by the enzymatic method ([@B16]). The protein amounts were determined by the bicinchoninic acid assay (BCA; [@B34]) in the presence of 5% SDS. For ATP synthesis rate measurements, mitochondria (0.15 mg/ml) were placed in a 1-ml thermostatically controlled chamber at 28°C in respiration buffer. The reaction was started by the addition of 4 mM NADH and 1 mM ADP and stopped with 3.5% perchloric acid and 12.5 mM EDTA. The samples were then neutralized to pH 6.5 by the addition of KOH and 0.3 M MOPS. ATP was quantified in a luciferin/luciferase assay (PerkinElmer) with an LKB bioluminometer. The specific ATPase activity was measured at pH 8.4 by using a previously described procedure ([@B35]). The activity of the F~1~F~0~-ATP synthase in ATP production was assessed by oligomycin addition (20 μg/mg of protein). BN-PAGE experiments were carried out as described previously ([@B32]). Briefly, mitochondrial extracts solubilized with digitonin to a protein ratio of 2 g/g were separated in a 3--12% acrylamide continuous gradient gel (Invitrogen). After electrophoresis, the gel was either stained with Coomassie Blue or incubated in a solution of 5 mM ATP, 5 mM MgCl~2~, 0.05% lead nitrate, 50 mM glycine-NaOH, pH 8.4 to detect the ATPase activity ([@B15]). Western blot analyses were performed as previously described ([@B6]). Polyclonal antibodies raised against yeast ATP synthase were used at a dilution of 1:50,000 for subunits Atp1; 1:10,000 for subunits Atp3 and Atp4. Monoclonal antibodies against yeast Porin and Cox2 (from Molecular Probes) were used at a dilution of 1:5,000. Nitrocellulose membranes were incubated with peroxidase-labeled antibodies at a 1:5,000 dilution (Promega), and the blot visualization was conducted with ECL reagent (Pierce).

Results
=======

Heterologous Expression of the Human Epsilon Subunit in yeast
-------------------------------------------------------------

To model the ε-Y12C mutation in yeast, we first determined whether the WT human ε-subunit was able to complement yeast cells lacking the endogenous ε-subunit gene *ATP15* (Δ*atp15*, referred to as Δε). Since Δε cells have a high propensity to lose their mitochondrial genome ([@B38]), we proceeded as follows. WT yeast was first transformed with the yeast *ATP15* gene cloned into a plasmid under the control of a doxycycline-repressible promoter. The native chromosomal copy of *ATP15* was then deleted, yielding strain YE1 ([@B38]). The strain YE1 was next transformed with a plasmid containing the human ε-subunit gene (ATP5E), also under control of a doxycycline-repressible promoter, and the plasmid containing the yeast *ATP15* gene was then eliminated (see "Materials and Methods"), yielding the strain hATP5E.

The hATP5E and YE1 strains grew well on fermentable carbon source (glucose, **Figure [1A](#F1){ref-type="fig"}**). The strain YE1 grew well also on non-fermentable carbon sources, like glycerol and lactate (**Figure [1A](#F1){ref-type="fig"}**). As expected, the respiratory growth of strain YE1 was abolished by blocking the expression of yeast subunit ε with doxycycline. In contrast, hATP5E cells expressing the human ε-subunit grew very poorly on respiratory medium (Glycerol or Lactate) with respect to YE1 cells (**Figure [1A](#F1){ref-type="fig"}**).

![**Heterologous expression assays of human ε-subunit in yeast. (A)** Freshly grown cells of yeast expressing, human epsilon subunit (hATP5E) and WT yeast epsilon subunit (YE1) were spotted onto glucose, glycerol, and lactate media. Doxycyclin was added on plate at the concentration of 10 μg/mL. The plates were incubated at 28°C. **(B)** Sequence alignment between human and yeast ε-subunit. Identical amino acids are highlighted in black, similar amino acids in gray. Mutated Y12C in human or Y11C in yeast sequences is indicated by an arrow. Identity 37%, similarity 59%.](fgene-06-00159-g001){#F1}

Although the yeast and human ε-subunit display a high level of evolutionary conservation, the two proteins show a number of amino-acids differences (**Figure [1B](#F1){ref-type="fig"}**). It is possible that the human protein cannot interact properly with the yeast subunits δ and γ. However, since cultures of the hATP5E strain contained only less than 5% of *petites* lacking functional mtDNA, it can be inferred that the human ε-subunit was probably assembled but functions poorly. Indeed, as we have shown, a lack in subunit ε in yeast results in massive protons that strongly destabilize the mitochondrial genome ([@B38]).

Properties of Yeast Cells Expressing the Yeast ε-Subunit Carrying an Equivalent (Y11C) of the Human ε-Y12C Mutation
-------------------------------------------------------------------------------------------------------------------

Due to the lack of complementation of Δε yeast with the human ε-subunit gene, we decided to investigate the consequences of the ε-Y12C mutation using the yeast subunit ε with an equivalent of this mutation. The strain YE1 was transformed with this construct, yielding strain Y11C (see "Materials and Methods").

### Respiratory Growth and Oxygen Consumption

Y11C strain exhibited a nearly identically growth on both fermentable (glucose) and non-fermentable (glycerol, lactate) carbon sources (**Figure [2A](#F2){ref-type="fig"}**). This does not imply that the Y11C mutation has no deleterious effects, since the rate of ATP synthesis by the ATP synthase needs to be decreased by more than 70--80% in yeast to see an obvious respiratory growth defect ([@B26]).

![**Biochemical analysis of yeast ε-Y11C mutant. (A)** Freshly grown cells of WT (YE1) and the mutant Y11C (Y11C) were spotted onto glucose, glycerol, and lactate media. The plates were incubated at 28°C. **(B)** Oxygen consumption was measured on isolated mitochondria from WT strain YE1 and mutant Y11C grown in glycerol/ethanol 2% medium at 28°C. Additions were 0.15 mg/ml proteins, 4 mM NADH, 150 μM ADP and 4 μM CCCP (carbonyl cyanide *m*-chlorophenylhydrazone). The YE1 and Y11C cultures contained about 3--5% ρ^-/0^ cells. **(C**,**D)** Measurements of ATP synthase/ATPase activity on purified mitochondria from cells grown on glycerol/ethanol 2%. White bar in ATP synthesis/hydrolysis represent oligomycin insensitive ATPase activity and % of inhibition was indicated on the bar. The values reported are averages of triplicate assays. **(E)** BN-PAGE analyses of the ATP synthase. Mitochondria from WT (YE1) strain and yeast Y11C mutant (Y11C) from cells grown on glycerol/ethanol 2%, were solubilized with digitonin (2 g digitonin/g of protein). After centrifugation, the mitochondrial complexes were separated by BN-PAGE and the gels incubated with ATP and lead nitrate to reveal the ATPase activity (right) followed by their staining with Coomassie Blue (left). V~1~ and V~2~ correspond to monomeric and dimeric ATP synthase, respectively, and III~2~--IV~2~; III~2~--IV~1~ and III~2~ correspond to super-complexes III and IV. **(F)** Total extract proteins were separated via SDS--PAGE and probed with antibodies against the indicated proteins.](fgene-06-00159-g002){#F2}

We next measured the rate of oxygen consumption on isolated mitochondria. Using NADH as an electron donor, this activity was reduced by approximately 20% in mitochondria from the Y11C mutant with respect to those from the WT strain YE1, at state 3 (i.e., in the presence of an excess of external ADP, phosphorylating conditions; **Figure [2B](#F2){ref-type="fig"}**). With the addition of NADH alone (state 4, basal respiration) respiration was in contrast slightly increased in Y11C mitochondria in comparison to WT mitochondria, which is an indication that the passive permeability to protons of the inner membrane was increased in the mutant. Hence, the oxygen consumption rate was significantly less stimulated by ADP in the mutant than in the WT (2.4-fold versus 3.7), which indicates that the rate of ADP phosphorylation by the ATP synthase was slower in the mutant. The increased passive permeability to protons was attributed to a slight instability of the expression system used (pES425, see "Materials and Methods"), leading to an uncoupling of cells having lost the plasmid ([@B38]), but not necessarily an instability of ε-subunit in the ATP synthase complex.

### Mitochondrial ATP Synthesis/Hydrolysis and ATP Synthase Assembly/Stability

The impact of the Y11C mutation on OXPHOS was further analyzed by measuring the rate of mitochondrial ATP synthesis with NADH as a respiratory substrate, in the presence of large excess of ADP (state 3). This activity was substantially reduced in the Y11C mutant by 40% compared with the WT (**Figure [2C](#F2){ref-type="fig"}**). As previously explained (see above), a small uncoupling will lead to a decrease in the ATP synthesis activity which does not necessarily reflect the impact of Y11C mutation. With only a 40% deficit in ATP production, it is normal that the Y11C mutant grew well on respiratory substrates, for reasons explained above.

The rate of mitochondrial ATP hydrolysis (measured on non-osmotically protected mitochondria) was not diminished, with respect to the WT, by the Y11C mutation. Furthermore, this activity was normally inhibited by oligomycin, indicating that the physical and functional coupling of F~1~ to F~0~ was mainly preserved in the mutant (**Figure [2D](#F2){ref-type="fig"}**). Consistent with this, the mutated F~1~F~0~-ATPase was correctly assembled and accumulated normally in Y11C cells, as shown by BN-PAGE (**Figure [2E](#F2){ref-type="fig"}**) and SDS-PAGE (**Figure [2F](#F2){ref-type="fig"}**) analyses.

Discussion
==========

Biochemical investigation of fibroblasts from patients carrying the ε-Y12C has revealed a substantial decrease (60%) in the accumulation of fully assembled ATP synthase with respect to control cells. Similar decreases in the rate of mitochondrial ATP synthesis and ATP hydrolysis, and in the steady-state concentrations of various subunits belonging to the F~1~ (α, β, ε) or the F~0~ (a, F6, d), were observed in the ε-Y12C cells ([@B25]). When expression of WT ATP5E gene encoding ε-subunit was reduced, the biogenesis of ATP synthase was similarly inhibited ([@B17]). However, neither the ε-Y12C mutation nor a block in ε-subunit expression affects the steady-state accumulation of subunit *c*, which argues against a role of ε-subunit expression in the regulation of human ATP synthase biogenesis. Such a role has instead been ascribed to subunit *c* whose level of expression was shown to determine the steady-state concentrations of all the other subunits of the enzyme ([@B19]; [@B4]). Indeed, in the absence of subunit *c*, all the other ATP synthase subunits continue to be expressed at the same levels, but because of the lack in subunit *c* they cannot assemble into complete F~1~F~0~ complexes and are degraded ([@B19]).

Studies in yeast have revealed that in the absence of ε-subunit, the other subunits of ATP synthase can still assemble. However, mitochondrial respiration is then uncoupled due to F~0~-mediated proton leaks across the mitochondrial inner membrane ([@B38]). It is believed that ε-subunit is required to maintain δ-subunit in the ATP synthase under the torque imposed on this subunit during rotation of the *c*-subunit ring. Upon the loss of δ-subunit, the F~0~ can no longer associate to the F~1~ and the F~0~ then dissipates the mitochondrial membrane potential. Based on the current structural models of yeast and bovine F~1~ (**Figure [3A](#F3){ref-type="fig"}**), there is every reason to believe that ε-subunit has a similar role in human ATP synthase. However, contrary to what happens in yeast, a functional F~0~ does not assemble in the absence of ε-subunit in humans, with notably the absence of subunit *a* where are located most of the residues involved in F~0~-mediated proton movements. Furthermore, it was shown that while unassembled F~1~ subunits aggregate in the matrix of yeast mitochondria, they are rapidly degraded in HeLa cells ([@B29]). It can be inferred that different mechanisms regulate the expression of F~0~ in humans and yeast.

![**Model of mutated ε-subunit. (A)** Alignment of γδε-subunits of bovin (2XND.pdb) and yeast (2WPD.pdb) ATP synthase built with PyMOL. γ, δ, and ε-subunits were colored in blue, orange and green, respectively. **(B)** Magnification of panel A. Yeast tyrosine (Y11, red) of ε-subunit and interaction with δ-subunit (δ-G73, δ-L52 in blue) are indicated by yellow dashed line. **(C)** Magnification of panel A and modelisation of the mutated tyrosine 11 in cysteine on the yeast ε-subunit (C11, yellow).](fgene-06-00159-g003){#F3}

The decreased content in ε-subunit in Y12C fibroblasts is possibly due to a less efficient incorporation/stability of the mutated protein into the ATP synthase, followed by a rapid degradation of the unassembled protein. However, the present study shows that the pathogenic ε-subunit mutation (Y12C, in humans; Y11C in yeast) does not compromise the assembly of ε-subunit in yeast. Based on this finding, we propose that the lack in ε-subunit in the patient's fibroblasts has possibly another cause than a defective assembly, like a less efficient transport of this protein into mitochondria or an increased susceptibility of the mutated protein to proteolytic degradation. It is conceivable that the ε-subunit interacts with some unknown protein until its incorporation into ATP synthase, and that this interaction is disrupted by the ε-subunit mutation making the ε-subunit more prone to degradation.

A 60% decrease in the rate of mitochondrial ATP synthesis was observed in the Y12C fibroblasts. Since, the content in fully assembled ATP synthase was decreased in a similar proportion, it was concluded that once assembled the mutated ε-subunit works like the WT protein ([@B25]). In a similar way to humans, the ATPase/synthase activities of the yeast ATP synthase seems little affected by ε-subunit mutation, suggesting that this mutation has little or no impact on the functioning of ATP synthase. The mutated tyrosine residue establishes a few interactions with δ-subunit that are predicted to be lost by replacing this residue with cysteine (see **Figures [3B,C](#F3){ref-type="fig"}**). These interactions are apparently not essential for the maintenance of δ-subunit within ATP synthase. However, unlike to what has been observed in humans, the assembly of the yeast ATP synthase was not affected at all by ε-subunit mutation, suggesting differences in assembly/stability of the ATP synthase between yeast and humans.

In summary, if the ε-subunit mutation found in patients is detrimental to mitochondrial energy-transduction in humans, this mutation does not appear to have a strong impact on the yeast mitochondrial ATP synthase. The findings reported in this study point to the existence of important differences in the regulation of ATP synthase biogenesis between yeast and humans, an issue that would certainly deserve further studies for a better comprehension of how the mechanisms involved in mitochondrial biogenesis adapted during the evolution of eukaryotes.
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